The global rat model market size was US$ 636 million in 2021. The global rat model market size is forecast to reach US$ 1,327 million by 2030, growing at a compound annual growth rate (CAGR) of 8.6% during the forecast period from 2022 to 2030.
A rat model is a non-human, living, genetically modified animal utilized in scientific study and the exploration of human diseases. These rat models have also been utilized to gain a better knowledge of the human disease process without causing harm to humans. Because their pathophysiology is similar to disease situations that are similar in humans, rat models resemble human disease. The recurrence and course of rat diseases are identical to those of humans under certain situations. Because rats and humans have so many anatomical and physiological similarities, researchers have used these study models to investigate a wide range of causes and test new therapeutics.
Factors Influencing Market Growth
Impact Analysis of COVID-19
The COVID-19 pandemic had a positive impact on the global market. Despite the pandemic, heavy investments in COVID-19 research and increased financing for R&D initiatives to develop novel treatments have encouraged the use of rat testing. Several pharmaceutical businesses, biotechnology corporations, and clinical research organizations changed their clinical trial R&D spending in contrast to the previous spending, reflecting the pandemic's extent of disruption. As a result, clinical research and development operations were continued, ensuring the inflow and use of rat models. Therefore, aiding the expansion of the rat model market.
Regional Analysis
North America accounted for a major market share in 2021 and is forecast to have substantial growth during the forecast period. As a result of the rising research activities, increasing demand for personalized medication, and a surge in healthcare expenditure.
The Asia Pacific region is forecast to have lucrative growth during the forecast period. As a result of the rising number of academic and contract research organizations in leading countries like Japan, China, Australia, and India.
Leading Competitors
The leading prominent companies profiled in the global rat model market are:
Scope of the Report
The global rat model market segmentation focuses on Type, Technology, Service, Application, End-Use, and Region.
Segmentation based on Type
Segmentation based on Technology
Segmentation based on Service
Segmentation based on Application
Segmentation based on End-Use
Segmentation based on Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL RAT MODEL MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
4 GLOBAL RAT MODEL MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE MODEL
4.4 VALUE CHAIN ANALYSIS
5 GLOBAL RAT MODEL MARKET, BY TYPE
5.1 OVERVIEW
5.2 OUTBRED RATS
5.3 INBRED RATS
5.4 GENETICALLY MODIFIED RATS
5.5 HYBRID/CONGENIC RATS
5.6 CONDITIONED/SURGICALLY MODIFIED RATS
5.7 IMMUNODEFICIENT RATS
6 GLOBAL RAT MODEL MARKET, BY TECHNOLOGY
6.1 OVERVIEW
6.2 NUCLEAR TRANSFER
6.3 EMBRYONIC STEM CELL
6.4 MICROINJECTION
6.5 OTHERS
7 GLOBAL RAT MODEL MARKET, BY SERVICE
7.1 OVERVIEW
7.2 CRYOPRESERVATION
7.3 BREEDING
7.4 REDERIVATION
7.5 GENETIC TESTING
7.6 QUARANTINE DEPENDING
7.7 OTHER
8 GLOBAL RAT MODEL MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 ONCOLOGY
8.3 NEUROLOGY
8.4 IMMUNOLOGY
8.5 TOXICOLOGY
8.6 OTHERS
9 GLOBAL RAT MODEL MARKET, BY END-USE
9.1 OVERVIEW
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.3 ACADEMIC & RESEARCH INSTITUTES
9.4 CONTRACT RESEARCH ORGANIZATIONS (CROS)
10 GLOBAL RAT MODEL MARKET, BY GEOGRAPHY
10.1 OVERVIEW
10.2 NORTH AMERICA
10.2.1 NORTH AMERICA MARKET SNAPSHOT
10.2.2 U.S.
10.2.3 CANADA
10.2.4 MEXICO
10.3 EUROPE
10.3.1 EUROPE MARKET SNAPSHOT
10.3.2 WESTERN EUROPE
10.3.2.1 THE UK
10.3.2.2 GERMANY
10.3.2.3 FRANCE
10.3.2.4 ITALY
10.3.2.5 SPAIN
10.3.2.6 REST OF WESTERN EUROPE
10.3.3 EASTERN EUROPE
10.3.3.1 POLAND
10.3.3.2 RUSSIA
10.3.3.3 REST OF EASTERN EUROPE
10.4 ASIA PACIFIC
10.4.1 ASIA PACIFIC MARKET SNAPSHOT
10.4.2 CHINA
10.4.3 JAPAN
10.4.4 INDIA
10.4.5 AUSTRALIA & NEW ZEALAND
10.4.6 ASEAN
10.4.7 REST OF ASIA PACIFIC
10.5 MIDDLE EAST & AFRICA
10.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
10.5.2 UAE
10.5.3 SAUDI ARABIA
10.5.4 SOUTH AFRICA
10.5.5 REST OF MEA
10.6 SOUTH AMERICA
10.6.1 SOUTH AMERICA MARKET SNAPSHOT
10.6.2 BRAZIL
10.6.3 ARGENTINA
10.6.4 REST OF SOUTH AMERICA
11 GLOBAL RAT MODEL MARKET COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 COMPANY MARKET RANKING
11.3 KEY DEVELOPMENT STRATEGIES
12 COMPANY PROFILES
12.1 GENOWAY
12.1.1 OVERVIEW
12.1.2 FINANCIAL PERFORMANCE
12.1.3 PRODUCT OUTLOOK
12.1.4 KEY DEVELOPMENTS
12.2 CHARLES RIVER LABORATORIES INTERNATIONAL, INCORPORATED
12.2.1 OVERVIEW
12.2.2 FINANCIAL PERFORMANCE
12.2.3 PRODUCT OUTLOOK
12.2.4 KEY DEVELOPMENTS
12.3 ENVIGO
12.3.1 OVERVIEW
12.3.2 FINANCIAL PERFORMANCE
12.3.3 PRODUCT OUTLOOK
12.3.4 KEY DEVELOPMENTS
12.4 COVANCE INCORPORATED
12.4.1 OVERVIEW
12.4.2 FINANCIAL PERFORMANCE
12.4.3 PRODUCT OUTLOOK
12.4.4 KEY DEVELOPMENTS
12.5 HORIZON DISCOVERY GROUP PLC
12.5.1 OVERVIEW
12.5.2 FINANCIAL PERFORMANCE
12.5.3 PRODUCT OUTLOOK
12.5.4 KEY DEVELOPMENTS
12.6 JANVIER LABS
12.6.1 OVERVIEW
12.6.2 FINANCIAL PERFORMANCE
12.6.3 PRODUCT OUTLOOK
12.6.4 KEY DEVELOPMENTS
12.7 TACONIC BIOSCIENCES, INCORPORATED
12.7.1 OVERVIEW
12.7.2 FINANCIAL PERFORMANCE
12.7.3 PRODUCT OUTLOOK
12.7.4 KEY DEVELOPMENTS
12.8. BIOMEDICAL RESEARCH MODELS (BIOMERE)
12.8.1 OVERVIEW
12.8.2 FINANCIAL PERFORMANCE
12.8.3 PRODUCT OUTLOOK
12.8.4 KEY DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved